American biotechnology firm focused on infectious-disease vaccines
Major U.S. medical societies have published coordinated guidance for flu, COVID-19 and RSV vaccinations after the FDA approved updated COVID and flu shots. The American Medical Association and partner groups have compiled evidence and tailored recommendations for age and risk groups while the CDC advisory process remains delayed by political and legal disputes. Enhanced and mRNA flu options are available for older adults.
Flu vaccines are underway and updated COVID-19 shots are arriving nationwide after FDA approval. RSV remains a threat, prompting guidance from medical societies as Trump health officials rethink autumn vaccine policies. An advisory panel remains in a legal dispute, while doctors push clear, science-based guidance. Older adults and high-risk groups are urged to vaccinate, with a new mRNA flu shot showing improved effectiveness.